2021
-
Low-Dose CT Screening with Guidance from Biomarkers May be Beneficial for Some Patients Who Have Never Smoked
Although about 20% of those who die of lung cancer in the United States each year have never smoked,1 only individuals with heavy smoking histories are eligible for low-dose CT […]
-
Strategies for Implementing Lung Cancer Screening Programs in Low-Middle Income Countries
A wide range of nations at various stages of economic and health-system development fall under the umbrella of low- and middle-income countries (LIMC). As Lucía Viola, MD, of the Fundación […]
-
Low-Dose CT Could be One-Stop Test for Early Signs of China’s ‘Big Three’ Chest Diseases
Finding one effective test for the three chest conditions that are the leading causes of death in China, without a high risk of false positives, would allow better control of […]
-
The 50-year Journey to Optimize Lung Cancer Screening Programs
The first forays into lung cancer screening began in the 1970s, with two trials evaluating the use of chest x-ray and sputum cytology to detect disease. Those trials showed no […]
-
Optimizing CT Performance Through Use of Tumor Phantoms
Even the most advanced CT scanners available face limitations in their ability to measure small lung nodules. This is a concern since small errors in two-dimensional measures can quickly balloon […]
-
IASLC Studying Impact of COVID-19 on International Lung Cancer Clinical Trial Enrollment, Mitigation Strategies
Although clinical trials are vitally important to researchers working to improve therapies for lung cancer, clinical trials also provide what could be lifesaving treatments to those patients on trials. When […]
-
Advancing Combined Modality Therapy for Early-Stage, Screen-Detected Disease: Adjuvant/Neoadjuvant Therapy
During the 17th annual Quantitative Imaging Workshop held in late Fall 2020, the Initiative for Early Lung Cancer Research on Treatment (IELCART) offered two sessions with panel discussions exploring the […]
-
Differences in Smoking and Lung Cancer Incidence Among Black and White Young Adults in the United States
In the United States, racial disparities in lung cancer incidence are known to exist. This is most likely caused by higher smoking prevalence among non-Hispanic Black adults compared to non-Hispanic […]
-
Prolonging CT Screening Intervals is Deemed Safe in Individuals with Negative Baseline Results
In his May 7 presentation “Advance Lung Cancer Screening Globally,” Dr. Pastorino, co-chair of the CT Screening Symposium and director of the Thoracic Surgery Division at the Istituto Nazionale Tumori in Milan, discussed the MILD, BioMILD, and SMILE trials. He also is chair of the IASLC’s Screening and Early Detection Committee.
-
The IASLC Mourns the Loss of Dr. Gouri Bhattacharyya
Gouri Shankar Bhattacharyya, MD, FRCP, died this past week of COVID-19–related complications. A medical oncologist in Kolkata, India, with 25 years of experience, Dr. Bhattacharyya’s special interests were many and […]
View ILCN Archives
Provider Resources